Related Experiment Video
Updated: Jan 14, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
On the Two-Step Hybrid Design for Augmenting Randomized Trials Using Real-World Data
Jiapeng Xu1, Ruben P A van Eijk1,2, Alicia Ellis3
1Department of Biomedical Data Science and Center for Innovative Study Design, Stanford University School of Medicine, California, CA.
Hybrid clinical trials use real-world data (RWD) to enhance randomized trials, especially for rare diseases. New methods control Type I error rates when RWD and trial data are exchangeable, improving trial validity.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Real-World Data Analysis
Background:
- Hybrid clinical trials integrate real-world data (RWD) with randomized controlled trials (RCTs).
- These trials are crucial for rare diseases where patient recruitment is challenging.
- A key assumption is the exchangeability of RWD and RCT control arms, which if violated, can introduce bias and affect statistical accuracy.
Purpose of the Study:
- To propose and evaluate novel methods for controlling Type I error rates in hybrid clinical trials.
- To assess the performance of these methods under varying degrees of exchangeability between RWD and RCT data.
- To compare the proposed methods against existing approaches like the Yuan et al. (2019) and Bayesian power prior methods.
Main Methods:
- Four new methods were developed to control Type I error under the exchangeability assumption.
- Methods involve variance estimation, numerical critical value determination, and Type I error rate splitting.
- The performance was evaluated using a hypothetical amyotrophic lateral sclerosis (ALS) scenario, assessing Type I error and statistical power.
Main Results:
- The proposed methods and the Bayesian power prior approach effectively control Type I error and increase power when exchangeability holds.
- The Yuan et al. (2019) method showed an increased Type I error.
- When exchangeability is violated, all methods struggle; however, the proposed methods demonstrate limited Type I error inflation (6-8%) compared to others.
Conclusions:
- The proposed methods offer robust Type I error control in hybrid trials under the exchangeability assumption.
- These methods, along with the Bayesian power prior, enhance statistical power when RWD and RCT data are exchangeable.
- The proposed methods provide a more controlled inflation of Type I error when the exchangeability assumption is not met, offering a safer approach for hybrid trial design.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
08:58Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
Published on: October 17, 2025
Related Concept Videos
Randomized Experiments
Simple randomization
Simple...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Experimental Designs
Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...